Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer

Journal of Breath Research

Volumn 8, Issue 2, 2014, Pages

  Brussino, Luisa ^a   Culla, Beatrice ^a   Bucca, Caterina ^a   Giobbe, Roberto ^b   Boita, Monica ^a   Isaia, Giancarlo ^a   Heffler, Enrico ^a   Oliaro, Alberto ^b   Filosso, Pierluigi ^b   Rolla, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

exhaled breath condensate; interleukin 17; lymphocyte T helper 17; non small cell lung cancer; tumor necrosis factor alfa; vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CYTOKINE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH17 CELL; TUMOR VOLUME; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; EXHALATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREATH TESTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CYTOKINES; EXHALATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-6; LIMIT OF DETECTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901624195     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/8/2/027110     Document Type: Article

References (46)

1. Ferlay J, Shin H R, Bray F, Forman D, Mathers C and Parkin D M 2010 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2893-917
2. Panico F, Rizzi F, Fabbri L M, Bettuzzi S and Luppi F 2009 Clusterin (CLU) and lung cancer Adv. Cancer Res. 105 63-76
3. Konvalina G and Haick H 2013 Sensors for breath testing: from nanomaterials to comprehensive disease detection Acc. Chem. Res. 47 66-76
4. Broza Y Y and Haick H 2013 Nanomaterial-based sensors for detection of disease by volatile organic compounds Nanomedicine 8 785-806
5. Hakim M, Broza Y Y, Barash O, Peled N, Phillips M, Amann A and Haick H 2012 Volatile organic compounds of lung cancer and possible biochemical pathways Chem. Rev. 112 5949-66
6. Mantovani A, Allavena P, Sica A and Balkwill F 2008 Cancer-related inflammation Nature 454 436-44
7. Sethi G, Shanmugam M K, Ramachandran L, Kumar A P and Tergaonkar V 2012 Multifaceted link between cancer and inflammation Biosci. Rep. 32 1-15
8. Aggarwal B B and Gehlot P 2009 Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 9 351-69
9. Kryczek I et al 2009 Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 1141-9
10. Martin-Orozco N, Muranski P, Chung Y, Yang X O, Yamazaki T, Lu S, Hwu P, Restifo N P, Overwijk W W and Dong C 2009 T helper 17 cells promote cytotoxic T cell activation in tumor immunity Immunity 31 787-98
11. Wilke C M, Kryczek I, Wei S, Zhao E, Wu K, Wang G and Zou W 2011 Th17 cells in cancer: help or hindrance? Carcinogenesis 32 643-9
12. Ye Z J, Zhou Q, Zhang J C, Xin J B and Shi H Z 2011 CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism Respir. Res. 12 77
13. Zhang Q et al 2012 Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models Cancer Res. 72 2589-99
14. Zhang J P, Yan J, Xu J, Pang X H, Pang X H, Chen M S, Li L, Wu C, Li S P and Zheng L 2009 Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients J. Hepatol. 50 980-9
15. Chen X, Wan J, Liu J, Li X, Wu C, Quin S M, Zhu B and Chen Z 2010 Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients Lung Cancer 69 348-54
16. Numasaki M, Lotze M T and Sasaki H 2004 Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts Immunol. Lett. 93 39-43 (Pubitemid 38591518)
17. Kato T, Furumoto H, Ogura T, Kamada M and Aono T 2001 Expression of IL-17 mRNA in ovarian cancer Biochem. Biophys. Res. Commun. 282 735-8 (Pubitemid 32924619)
18. Iida T et al 2011 Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer Oncol. Rep. 25 1271-7
19. Numasaki M et al 2005 IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis J. Immunol. 175 6177-89 (Pubitemid 41508106)
20. Ferrara N, Gerber HP and LeCouter J 2003 The biology of VEGF and its receptors Nature Med. 9 669-76 (Pubitemid 36749215)
21. Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, Lin Z and Zhu B 2011 IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma Biochem. Biophys. Res. Commun. 407 348-54
22. Hunt J 2007 Exhaled breath condensate- an overview Immunol. Allergy Clin. North Am. 27 587-96
23. Carpagnano G E, Resta O, Foschino-Barbaro M P, Gramiccioni E and Carpagnano F 2002 Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer Int. J. Biol. Markers 17 141-5 (Pubitemid 34873801)
24. Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, Ruschpler P and Wirtz H 2010 Angiogenic markers in breath condensate identify non-small cell lung cancer Lung Cancer 68 177-84
25. Carpagnano G E, Foschino Barbaro M P, Cagnazzo M, Di Gioia G, Giliberti T, Di Matteo C and Resta O 2005 Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge Chest 128 3159-66 (Pubitemid 41698636)
26. Charles K A et al 2009 The tumor-promoting actions of TNF-α involve TNF-R1 and IL-17 in ovarian cancer in mice and humans J. Clin. Invest. 119 3011-23
27. Chen J et al 2013 A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk J. Cancer Res. Clin. Oncol. 139 231-42
28. Gu F M et al 2011 IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma Mol. Cancer 10 150-22
29. Sobin L, Gospodarowicz M and Wittekind C 2009 TNM Classification of Malignant Tumours 7th edn (Chichester: Wiley-Blackwell)
30. Horváth I, Hunt J, Barnes P J and On behalf of the ATS/ERS Task Force on Exhaled Breath Condensate 2005 Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J. 26 523-48
31. Kastelijn E A, Rijkers G T, Van Moorsel C H, Zanen P, Kwakkel-van Erp J M, Van De Graaf E A, Van Kessel D A, Grutters J C and Van Den Bosch J M 2010 Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome J. Heart Lung Transplant. 29 997-1008
32. Gannot G, Tangrea M A, Richardson A M, Flaig M J, Hewitt S M, Marcus E M, Emmert-Buck M R and Chuaqui R F 2007 Layered expression scanning: multiplex molecular analysis of diverse life science platforms Clin. Chim. Acta 376 9-16 (Pubitemid 44895543)
33. Scott W J, Howington J, Feigenberg S, Movsas B and Pisters K 2007 Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 234S-42S (Pubitemid 47502810)
34. Long J S and Freese J 2006 Models for nominal outcomes with case-specific data Regression Models for Categorical Dependent Variables Using Stata (2nd edition) (College Station, TX: Stata Press)
35. Rabe-Hesketh S and Skrondal A 2005 Linear random-coefficient and growth-curve models Multilevel and Longitudinal Modeling Using Stata (College Station (TX): Stata Press)
36. Goldoni M et al 2013 Concentration of exhaled breath condensate biomarkers after fractionated collection based on exhaled CO2 signal J. Breath Res. 7 017101
37. Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, Ruschpler P and Wirtz H 2010 Angiogenic markers in breath condensate identify non-small cell lung cancer Lung Cancer 68 177-84
38. Malerba M and Montuschi P 2012 Non-invasive biomarkers of lung inflammation in smoking subjects Curr. Med. Chem. 19 187-96
39. Foschino Barbaro M P, Carpagnano G E, Spanevello A, Cagnazzo M G and Barnes P J 2007 Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease Int. J. Immunopathol. Pharmacol. 20 753-63
40. Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Hirano T, Nakanishi M, Yamagata T, Minakata Y and Ichinose M 2006 Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients J. Allergy Clin. Immunol. 118 84-90 (Pubitemid 43949586)
41. Luckheeram R V, Zhou R, Verma A D and Xia B 2012 CD4+ Cells: differentiation and functions Clin. Dev. Immunol. 2012 925135
42. Lee Y et al 2012 Induction and molecular signature of pathogenic TH17 cells Nature Immunol. 13 991-9
43. Kaminska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M and Steffen J 2006 Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor Oncology 70 115-25 (Pubitemid 43760337)
44. Peled N, Hakim M, Bunn P A Jr, Miller Y E, Kennedy T C, Mattei J, Mitchell J D, Hirsch F R and Haick H 2012 Non-invasive breath analysis of pulmonary nodules J. Thorac. Oncol. 7 1528-33
45. Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T and Ogura T 1995 Serum levels of interleukin 6 in patients with lung cancer Br. J. Cancer 71 1095-8
46. Pine S R, Mechanic L E, Enewold L, Chaturvedi A K, Katki H A, Zheng Y L, Bowman E D, Engels E A, Caporaso N E and Harris C C 2011 Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer J. Natl Cancer Inst. 103 1112-22